TreeWAS – Variant ID: rs4423886

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
Z92.6 Personal history of chemotherapy for neoplastic disease	0.253	0.747	0.000
Z92.4 Personal history of major surgery, not elsewhere classified	0.125	0.875	0.000
Z92 Personal history of medical treatment	0.122	0.878	0.000
Z92.3 Personal history of irradiation	0.089	0.911	0.000
Z92.9 Personal history of medical treatment, unspecified	0.088	0.912	0.000
Z92.5 Personal history of rehabilitation measures	0.088	0.912	0.000
J93.9 Pneumothorax, unspecified	0.000	0.923	0.077
Z92.0 Personal history of contraception	0.076	0.924	0.000
Z92.8 Personal history of other medical treatment	0.070	0.930	0.000
R22.1 Localised swelling, mass and lump, neck	0.000	0.932	0.068
R22.3 Localised swelling, mass and lump, upper limb	0.000	0.933	0.067
R22 Localised swelling, mass and lump of skin and subcutaneous tissue	0.000	0.936	0.064
R22.9 Localised swelling, mass and lump, unspecified	0.000	0.944	0.056
R22.2 Localised swelling, mass and lump, trunk	0.000	0.945	0.055
R22.0 Localised swelling, mass and lump, head	0.000	0.953	0.047
R22.7 Localised swelling, mass and lump, multiple sites	0.000	0.957	0.043
J93 Pneumothorax	0.000	0.963	0.037
Y43.3 Other antineoplastic drugs	0.032	0.968	0.000
J93.8 Other pneumothorax	0.000	0.969	0.031
J93.1 Other spontaneous pneumothorax	0.000	0.975	0.025
J93.0 Spontaneous tension pneumothorax	0.000	0.976	0.024
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.024	0.976	0.000
Y45.2 Propionic acid derivatives	0.024	0.976	0.000
Y43 Primarily systemic agents	0.023	0.977	0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.023	0.977	0.000
Y45.1 Salicylates	0.022	0.977	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.020	0.980	0.000
Y45.8 Other analgesics and antipyretics	0.020	0.980	0.000
C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum	0.020	0.980	0.000
Y52 Agents primarily affecting the cardiovascular system	0.019	0.981	0.000
M65.34 Trigger finger-Hand	0.019	0.981	0.000
N48.8 Other specified disorders of penis	0.018	0.982	0.000
Y43.1 Antineoplastic antimetabolites	0.018	0.982	0.000
Y57 Other and unspecified drugs and medicaments	0.018	0.982	0.000
Y45.4 Antirheumatics	0.017	0.983	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.017	0.983	0.000
F10.3 Withdrawal state	0.000	0.983	0.017
F10 Mental and behavioural disorders due to use of alcohol	0.000	0.983	0.017
Y43.9 Primarily systemic agent, unspecified	0.017	0.983	0.000
Y43.8 Other primarily systemic agents, not elsewhere classified	0.017	0.983	0.000
Y43.6 Enzymes, not elsewhere classified	0.017	0.983	0.000
Y43.5 Acidifying and alkalising agents	0.017	0.983	0.000
Y43.2 Antineoplastic natural products	0.017	0.983	0.000
F10.0 Acute intoxication	0.000	0.983	0.017
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.016	0.984	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.016	0.984	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.016	0.984	0.000
Y43.0 Antiallergic and antiemetic drugs	0.016	0.984	0.000
Y44 Agents primarily affecting blood constituents	0.016	0.984	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.015	0.984	0.000
Z92.1 Personal history of long-term (current) use of anticoagulants	0.015	0.985	0.000
R22.4 Localised swelling, mass and lump, lower limb	0.000	0.985	0.015
F10.2 Dependence syndrome	0.000	0.985	0.015
Y59 Other and unspecified vaccines and biological substances	0.015	0.985	0.000
Y58 Bacterial vaccines	0.015	0.985	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.015	0.985	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.015	0.985	0.000
Y57.6 Other diagnostic agents	0.015	0.985	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.015	0.985	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.014	0.986	0.000
Y57.5 X-ray contrast media	0.014	0.986	0.000
Y57.8 Other drugs and medicaments	0.014	0.986	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.014	0.986	0.000
F10-F19 Mental and behavioural disorders due to psychoactive substance use	0.000	0.986	0.014
D69.3 Idiopathic thrombocytopenic purpura	0.014	0.986	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.014	0.986	0.000
Y48 Anaesthetics and therapeutic gases	0.014	0.986	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.013	0.986	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.013	0.986	0.000
Y52.7 Peripheral vasodilators	0.013	0.986	0.000
Y46.6 Other and unspecified antiepileptics	0.013	0.986	0.000
Y45.5 4-Aminophenol derivatives	0.013	0.987	0.000
Y52.1 Calcium-channel blockers	0.013	0.987	0.000
F17.2 Dependence syndrome	0.000	0.987	0.013
Y49 Psychotropic drugs, not elsewhere classified	0.013	0.987	0.000
F10.5 Psychotic disorder	0.000	0.987	0.013
Y40 Systemic antibiotics	0.013	0.987	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.013	0.987	0.000
F10.9 Unspecified mental and behavioural disorder	0.000	0.987	0.013
Y57.7 Vitamins, not elsewhere classified	0.013	0.987	0.000
Y57.4 Pharmaceutical excipients	0.013	0.987	0.000
Y57.3 Alcohol deterrents	0.013	0.987	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.013	0.987	0.000
Y57.1 Lipotropic drugs	0.013	0.987	0.000
Y57.0 Appetite depressants [anorectics]	0.013	0.987	0.000
F11 Mental and behavioural disorders due to use of opioids	0.000	0.987	0.013
F10.8 Other mental and behavioural disorders	0.000	0.987	0.012
F10.7 Residual and late-onset psychotic disorder	0.000	0.987	0.012
F10.4 Withdrawal state with delirium	0.000	0.988	0.012
F17 Mental and behavioural disorders due to use of tobacco	0.000	0.988	0.012
F11.2 Dependence syndrome	0.000	0.988	0.012
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.012	0.988	0.000
C25.0 Head of pancreas	0.012	0.988	0.000
Y44.2 Anticoagulants	0.012	0.988	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.011	0.988	0.000
D69 Purpura and other haemorrhagic conditions	0.011	0.988	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.011	0.989	0.000
Y44.7 Plasma substitutes	0.011	0.989	0.000
Y44.6 Natural blood and blood products	0.011	0.989	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.011	0.989	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.011	0.989	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.011	0.989	0.000
Y44.5 Thrombolytic drugs	0.011	0.989	0.000
Y46.8 Antispasticity drugs	0.011	0.989	0.000
Y46.7 Anti-Parkinsonism drugs	0.011	0.989	0.000
Y46.5 Valproic acid	0.011	0.989	0.000
Y46.3 Deoxybarbiturates	0.011	0.989	0.000
Y46.1 Oxazolidinediones	0.011	0.989	0.000
Y46.0 Succinimides	0.011	0.989	0.000
Y46.4 Iminostilbenes	0.011	0.989	0.000
Y54.5 Other diuretics	0.011	0.989	0.000
Y40.1 Cefalosporins and other -lactam antibiotics	0.011	0.989	0.000
Y57.9 Drug or medicament, unspecified	0.011	0.989	0.000
Y40.4 Tetracyclines	0.011	0.989	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.011	0.989	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.011	0.989	0.000
Y50.9 Central nervous system stimulant, unspecified	0.011	0.989	0.000
Y50.8 Other central nervous system stimulants	0.011	0.989	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.011	0.989	0.000
Y50.1 Opioid receptor antagonists	0.011	0.989	0.000
Y50.0 Analeptics	0.011	0.989	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.011	0.989	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.011	0.989	0.000
Y55.5 Anticommon cold drugs	0.011	0.989	0.000
Y55.4 Expectorants	0.011	0.989	0.000
Y55.3 Antitussives	0.011	0.989	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.011	0.989	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.011	0.989	0.000
Y55.0 Oxytocic drugs	0.011	0.989	0.000
Y58.9 Other and unspecified bacterial vaccines	0.011	0.989	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.011	0.989	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.011	0.989	0.000
Y58.5 Diphtheria vaccine	0.011	0.989	0.000
Y58.4 Tetanus vaccine	0.011	0.989	0.000
Y58.3 Plague vaccine	0.011	0.989	0.000
Y58.2 Cholera vaccine	0.011	0.989	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.011	0.989	0.000
Y58.0 BCG vaccine	0.011	0.989	0.000
Y59.9 Vaccine or biological substance, unspecified	0.011	0.989	0.000
Y59.8 Other specified vaccines and biological substances	0.011	0.989	0.000
Y59.3 Immunoglobulin	0.011	0.989	0.000
Y59.2 Protozoal vaccines	0.011	0.989	0.000
Y59.1 Rickettsial vaccines	0.011	0.989	0.000
Y59.0 Viral vaccines	0.011	0.989	0.000
Y56.3 Emollients, demulcents and protectants	0.011	0.989	0.000
F10.6 Amnesic syndrome	0.000	0.989	0.011
Y53 Agents primarily affecting the gastro-intestinal system	0.011	0.989	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.011	0.989	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.011	0.989	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.011	0.989	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.011	0.989	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.011	0.989	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.011	0.989	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.011	0.989	0.000
Y51.0 Anticholinesterase agents	0.011	0.989	0.000
D65-D69 Coagulation defects, purpura and other haemorrhagic conditions	0.011	0.989	0.000
Y54.9 Mineral salts, not elsewhere classified	0.010	0.989	0.000
Y54.8 Agents affecting uric acid metabolism	0.010	0.989	0.000
Y54.7 Agents affecting calcification	0.010	0.989	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.010	0.989	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.010	0.989	0.000
Y54.0 Mineralocorticoids	0.010	0.989	0.000
C25.9 Pancreas, unspecified	0.010	0.989	0.000
C25 Malignant neoplasm of pancreas	0.010	0.990	0.000
F15 Mental and behavioural disorders due to use of other stimulants, including caffeine	0.000	0.990	0.010
Y48.3 Local anaesthetics	0.010	0.990	0.000
Y54.4 Loop [high-ceiling] diuretics	0.010	0.990	0.000
D69.5 Secondary thrombocytopenia	0.010	0.990	0.000
F19 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances	0.000	0.990	0.010
F18 Mental and behavioural disorders due to use of volatile solvents	0.000	0.990	0.010
F16 Mental and behavioural disorders due to use of hallucinogens	0.000	0.990	0.010
F14 Mental and behavioural disorders due to use of cocaine	0.000	0.990	0.010
F13 Mental and behavioural disorders due to use of sedatives or hypnotics	0.000	0.990	0.010
F10.1 Harmful use	0.000	0.990	0.010
Y49.5 Other antipsychotics and neuroleptics	0.010	0.990	0.000
Y56.9 Topical agent, unspecified	0.010	0.990	0.000
Y56.8 Other topical agents	0.010	0.990	0.000
Y56.7 Dental drugs, topically applied	0.010	0.990	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.010	0.990	0.000
Y56.5 Ophthalmological drugs and preparations	0.010	0.990	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.010	0.990	0.000
Y56.2 Local astringents and local detergents	0.010	0.990	0.000
Y56.1 Antipruritics	0.010	0.990	0.000
Y48.5 Therapeutic gases	0.010	0.990	0.000
Y48.1 Parenteral anaesthetics	0.010	0.990	0.000
Y48.0 Inhaled anaesthetics	0.010	0.990	0.000
F12 Mental and behavioural disorders due to use of cannabinoids	0.000	0.990	0.010
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.010	0.990	0.000
Z92.2 Personal history of long-term (current) use of other medicaments	0.010	0.990	0.000
Y48.2 Other and unspecified general anaesthetics	0.010	0.990	0.000
D68.9 Coagulation defect, unspecified	0.010	0.990	0.000
Y49.9 Psychotropic drug, unspecified	0.009	0.990	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.009	0.990	0.000
Y49.7 Psychostimulants with abuse potential	0.009	0.990	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.009	0.990	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.009	0.990	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.009	0.990	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.009	0.990	0.000
Y40.7 Antifungal antibiotics, systemically used	0.010	0.990	0.000
Y40.6 Rifamycins	0.010	0.990	0.000
Y40.5 Aminoglycosides	0.010	0.990	0.000
Y40.2 Chloramphenicol group	0.010	0.990	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.009	0.990	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.009	0.990	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.009	0.990	0.000
Y47.4 Bromine compounds	0.009	0.990	0.000
Y47.3 Paraldehyde	0.009	0.990	0.000
Y47.2 Chloral derivatives	0.009	0.990	0.000
Y47.0 Barbiturates, not elsewhere classified	0.009	0.990	0.000
Y40.8 Other systemic antibiotics	0.009	0.990	0.000
D68 Other coagulation defects	0.010	0.990	0.000
D66 Hereditary factor VIII deficiency	0.009	0.990	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.009	0.991	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.009	0.991	0.000
F11.9 Unspecified mental and behavioural disorder	0.000	0.991	0.009
F11.8 Other mental and behavioural disorders	0.000	0.991	0.009
F11.7 Residual and late-onset psychotic disorder	0.000	0.991	0.009
F11.6 Amnesic syndrome	0.000	0.991	0.009
F11.5 Psychotic disorder	0.000	0.991	0.009
F11.4 Withdrawal state with delirium	0.000	0.991	0.009
F11.3 Withdrawal state	0.000	0.991	0.009
F11.1 Harmful use	0.000	0.991	0.009
F11.0 Acute intoxication	0.000	0.991	0.009
Y52.4 Angiotensin-converting-enzyme inhibitors	0.009	0.991	0.000
Y40.3 Macrolides	0.009	0.991	0.000
M65.3 Trigger finger	0.009	0.991	0.000
Y46.2 Hydantoin derivatives	0.009	0.991	0.000
F17.9 Unspecified mental and behavioural disorder	0.000	0.991	0.009
F17.8 Other mental and behavioural disorders	0.000	0.991	0.009
F17.7 Residual and late-onset psychotic disorder	0.000	0.991	0.009
F17.6 Amnesic syndrome	0.000	0.991	0.009
F17.5 Psychotic disorder	0.000	0.991	0.009
F17.4 Withdrawal state with delirium	0.000	0.991	0.009
F17.3 Withdrawal state	0.000	0.991	0.009
F17.0 Acute intoxication	0.000	0.991	0.009
D69.9 Haemorrhagic condition, unspecified	0.009	0.991	0.000
Y48.4 Anaesthetic, unspecified	0.009	0.991	0.000
K07.3 Anomalies of tooth position	0.009	0.991	0.000
C25.2 Tail of pancreas	0.009	0.991	0.000
Y54.3 Benzothiadiazine derivatives	0.009	0.991	0.000
C25.8 Overlapping lesion of pancreas	0.009	0.991	0.000
Y41.0 Sulphonamides	0.008	0.991	0.000
D69.8 Other specified haemorrhagic conditions	0.008	0.991	0.000
D69.2 Other nonthrombocytopenic purpura	0.008	0.991	0.000
D69.1 Qualitative platelet defects	0.008	0.991	0.000
D68.6 Other Thrombophilia	0.008	0.992	0.000
M23.30 Other meniscus derangements (Multiple sites)	0.000	0.992	0.008
W20-W49 Exposure to inanimate mechanical forces	0.008	0.992	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.008	0.992	0.000
Y41.4 Anthelminthics	0.008	0.992	0.000
Y41.3 Other antiprotozoal drugs	0.008	0.992	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.008	0.992	0.000
Y41.1 Antimycobacterial drugs	0.008	0.992	0.000
C25.3 Pancreatic duct	0.008	0.992	0.000
Y43.4 Immunosuppressive agents	0.007	0.992	0.001
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.008	0.992	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.008	0.992	0.000
Y53.7 Emetics	0.008	0.992	0.000
Y53.6 Antidiarrhoeal drugs	0.008	0.992	0.000
Y53.5 Digestants	0.008	0.992	0.000
Y53.3 Saline and osmotic laxatives	0.008	0.992	0.000
Y53.2 Stimulant laxatives	0.008	0.992	0.000
Y53.0 Histamine H2-receptor antagonists	0.008	0.992	0.000
Chapter XX External causes of morbidity and mortality	0.008	0.992	0.000
H43.8 Other disorders of vitreous body	0.008	0.992	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.008	0.992	0.000
C25.7 Other parts of pancreas	0.008	0.992	0.000
F15.1 Harmful use	0.000	0.992	0.008
Y47.1 Benzodiazepines	0.008	0.992	0.000
D67 Hereditary factor IX deficiency	0.008	0.992	0.000
D65 Disseminated intravascular coagulation [defibrination syndrome]	0.008	0.992	0.000
D73 Diseases of spleen	0.008	0.992	0.000
Y45.0 Opioids and related analgesics	0.008	0.992	0.000
D68.0 Von Willebrand's disease	0.008	0.992	0.000
C25.4 Endocrine pancreas	0.008	0.992	0.000
V40-V49 Car occupant injured in transport accident	0.008	0.992	0.000
D69.4 Other primary thrombocytopenia	0.008	0.992	0.000
F15.9 Unspecified mental and behavioural disorder	0.000	0.992	0.008
F15.8 Other mental and behavioural disorders	0.000	0.992	0.008
F15.7 Residual and late-onset psychotic disorder	0.000	0.992	0.008
F15.6 Amnesic syndrome	0.000	0.992	0.008
F15.5 Psychotic disorder	0.000	0.992	0.008
F15.4 Withdrawal state with delirium	0.000	0.992	0.008
F15.3 Withdrawal state	0.000	0.992	0.008
F15.2 Dependence syndrome	0.000	0.992	0.008
F15.0 Acute intoxication	0.000	0.992	0.008
D68.5 Primary Thrombophilia	0.008	0.992	0.000
D73.0 Hyposplenism	0.008	0.992	0.000
W22 Striking against or struck by other objects	0.008	0.992	0.000
F13.9 Unspecified mental and behavioural disorder	0.000	0.992	0.007
F13.8 Other mental and behavioural disorders	0.000	0.992	0.007
F13.7 Residual and late-onset psychotic disorder	0.000	0.992	0.007
F13.6 Amnesic syndrome	0.000	0.992	0.007
F13.5 Psychotic disorder	0.000	0.992	0.007
F13.4 Withdrawal state with delirium	0.000	0.992	0.007
F13.3 Withdrawal state	0.000	0.992	0.007
F13.2 Dependence syndrome	0.000	0.992	0.007
F13.1 Harmful use	0.000	0.992	0.007
F13.0 Acute intoxication	0.000	0.992	0.007
F14.9 Unspecified mental and behavioural disorder	0.000	0.992	0.007
F14.8 Other mental and behavioural disorders	0.000	0.992	0.007
F14.7 Residual and late-onset psychotic disorder	0.000	0.992	0.007
F14.6 Amnesic syndrome	0.000	0.992	0.007
F14.5 Psychotic disorder	0.000	0.992	0.007
F14.4 Withdrawal state with delirium	0.000	0.992	0.007
F14.3 Withdrawal state	0.000	0.992	0.007
F14.2 Dependence syndrome	0.000	0.992	0.007
F14.1 Harmful use	0.000	0.992	0.007
F14.0 Acute intoxication	0.000	0.992	0.007
F16.9 Unspecified mental and behavioural disorder	0.000	0.992	0.007
F16.8 Other mental and behavioural disorders	0.000	0.992	0.007
F16.7 Residual and late-onset psychotic disorder	0.000	0.992	0.007
F16.6 Amnesic syndrome	0.000	0.992	0.007
F16.5 Psychotic disorder	0.000	0.992	0.007
F16.4 Withdrawal state with delirium	0.000	0.992	0.007
F16.3 Withdrawal state	0.000	0.992	0.007
F16.2 Dependence syndrome	0.000	0.992	0.007
F16.1 Harmful use	0.000	0.992	0.007
F16.0 Acute intoxication	0.000	0.992	0.007
F18.9 Unspecified mental and behavioural disorder	0.000	0.992	0.007
F18.8 Other mental and behavioural disorders	0.000	0.992	0.007
F18.7 Residual and late-onset psychotic disorder	0.000	0.992	0.007
F18.6 Amnesic syndrome	0.000	0.992	0.007
F18.5 Psychotic disorder	0.000	0.992	0.007
F18.4 Withdrawal state with delirium	0.000	0.992	0.007
F18.3 Withdrawal state	0.000	0.992	0.007
F18.2 Dependence syndrome	0.000	0.992	0.007
F18.1 Harmful use	0.000	0.992	0.007
F18.0 Acute intoxication	0.000	0.992	0.007
F19.9 Unspecified mental and behavioural disorder	0.000	0.992	0.007
F19.8 Other mental and behavioural disorders	0.000	0.992	0.007
F19.7 Residual and late-onset psychotic disorder	0.000	0.992	0.007
F19.6 Amnesic syndrome	0.000	0.992	0.007
F19.5 Psychotic disorder	0.000	0.992	0.007
F19.4 Withdrawal state with delirium	0.000	0.992	0.007
F19.3 Withdrawal state	0.000	0.992	0.007
F19.2 Dependence syndrome	0.000	0.992	0.007
F19.1 Harmful use	0.000	0.992	0.007
F19.0 Acute intoxication	0.000	0.992	0.007
Y49.2 Other and unspecified antidepressants	0.007	0.992	0.000
W29 Contact with other powered hand tools and household machinery	0.008	0.992	0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.007	0.992	0.000
Y40.9 Systemic antibiotic, unspecified	0.007	0.993	0.000
V90-V94 Water transport accidents	0.007	0.993	0.000
F12.9 Unspecified mental and behavioural disorder	0.000	0.993	0.007
F12.8 Other mental and behavioural disorders	0.000	0.993	0.007
F12.7 Residual and late-onset psychotic disorder	0.000	0.993	0.007
F12.6 Amnesic syndrome	0.000	0.993	0.007
F12.5 Psychotic disorder	0.000	0.993	0.007
F12.4 Withdrawal state with delirium	0.000	0.993	0.007
F12.3 Withdrawal state	0.000	0.993	0.007
F12.2 Dependence syndrome	0.000	0.993	0.007
F12.0 Acute intoxication	0.000	0.993	0.007
W26 Contact with knife, sword or dagger	0.007	0.993	0.000
W29.9 Unspecified place	0.007	0.993	0.000
R53 Malaise and fatigue	0.007	0.993	0.000
W44 Foreign body entering into or through eye or natural orifice	0.007	0.993	0.000
V01-V09 Pedestrian injured in transport accident	0.007	0.993	0.000
F12.1 Harmful use	0.000	0.993	0.007
Y53.4 Other laxatives	0.007	0.993	0.000
V49 Car occupant injured in other and unspecified transport accidents	0.007	0.993	0.000
V43 Car occupant injured in collision with car, pick-up truck or van	0.007	0.993	0.000
D68.4 Acquired coagulation factor deficiency	0.007	0.993	0.000
V93 Accident on board watercraft without accident to watercraft, not causing drowning and submersion	0.007	0.993	0.000
N13.8 Other obstructive and reflux uropathy	0.000	0.993	0.007
W50-W64 Exposure to animate mechanical forces	0.007	0.993	0.000
N13.2 Hydronephrosis with renal and ureteral calculous obstruction	0.007	0.993	0.000
Y41.5 Antiviral drugs	0.007	0.993	0.000
V49.9 Car occupant [any] injured in unspecified traffic accident	0.007	0.993	0.000
D86 Sarcoidosis	0.007	0.993	0.000
C25.1 Body of pancreas	0.007	0.993	0.000
W22.9 Unspecified place	0.007	0.993	0.000
D73.5 Infarction of spleen	0.007	0.993	0.000
W25 Contact with sharp glass	0.007	0.993	0.000
W85-W99 Exposure to electric current, radiation and extreme ambient air temperature and pressure	0.007	0.993	0.000
M65.39 Trigger finger-Site unspec	0.007	0.993	0.000
M65.38 Trigger finger-Other	0.007	0.993	0.000
M65.37 Trigger finger-Ankle/foot	0.007	0.993	0.000
M65.36 Trigger finger-Lower leg	0.007	0.993	0.000
M65.35 Trigger finger-Pelvic/thigh	0.007	0.993	0.000
M65.33 Trigger finger-Forearm	0.007	0.993	0.000
M65.32 Trigger finger-Upper arm	0.007	0.993	0.000
M65.31 Trigger finger-Shldr region	0.007	0.993	0.000
M65.30 Trigger finger-Mult sites	0.007	0.993	0.000
V80-V89 Other land transport accidents	0.007	0.993	0.000
K07 Dentofacial anomalies [including malocclusion]	0.007	0.993	0.000
D69.6 Thrombocytopenia, unspecified	0.007	0.993	0.000
W26.8 Other specified place	0.007	0.993	0.000
V43.9 Unspecified car occupant injured in traffic accident	0.007	0.993	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.007	0.993	0.000
D73.3 Abscess of spleen	0.007	0.993	0.000
F20.0 Paranoid schizophrenia	0.000	0.993	0.007
D86.8 Sarcoidosis of other and combined sites	0.007	0.993	0.000
D68.1 Hereditary factor XI deficiency	0.007	0.993	0.000
D70-D77 Other diseases of blood and blood-forming organs	0.007	0.993	0.000
C78 Secondary malignant neoplasm of respiratory and digestive organs	0.007	0.993	0.000
Y60-Y69 Misadventures to patients during surgical and medical care	0.007	0.993	0.000
V95-V97 Air and space transport accidents	0.007	0.993	0.000
D86.9 Sarcoidosis, unspecified	0.007	0.993	0.000
V93.1 Passenger ship	0.006	0.993	0.000
V50-V59 Occupant of pick-up truck or van injured in transport accident	0.006	0.993	0.000
D80-D89 Certain disorders involving the immune mechanism	0.006	0.994	0.000
W23 Caught, crushed, jammed or pinched in or between objects	0.006	0.994	0.000
C78.4 Secondary malignant neoplasm of small intestine	0.006	0.994	0.000
N80.1 Endometriosis of ovary	0.000	0.994	0.006
W22.5 Trade and service area	0.006	0.994	0.000
W44.0 Home	0.006	0.994	0.000
X00-X09 Exposure to smoke, fire and flames	0.006	0.994	0.000
D69.0 Allergic purpura	0.006	0.994	0.000
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use	0.006	0.994	0.000
W75-W84 Other accidental threats to breathing	0.006	0.994	0.000
C78.5 Secondary malignant neoplasm of large intestine and rectum	0.006	0.994	0.000
D73.1 Hypersplenism	0.006	0.994	0.000
Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	0.006	0.994	0.000
V02 Pedestrian injured in collision with two- or three-wheeled motor vehicle	0.006	0.994	0.000
W46 Contact with hypodermic needle	0.006	0.994	0.000
W43 Exposure to vibration	0.006	0.994	0.000
W42 Exposure to noise	0.006	0.994	0.000
W41 Exposure to high-pressure jet	0.006	0.994	0.000
W40 Explosion of other materials	0.006	0.994	0.000
W39 Discharge of firework	0.006	0.994	0.000
W38 Explosion and rupture of other specified pressurised devices	0.006	0.994	0.000
W37 Explosion and rupture of pressurised tyre, pipe or hose	0.006	0.994	0.000
W36 Explosion and rupture of gas cylinder	0.006	0.994	0.000
W35 Explosion and rupture of boiler	0.006	0.994	0.000
W34 Discharge from other and unspecified firearms	0.006	0.994	0.000
W33 Rifle, shotgun and larger firearm discharge	0.006	0.994	0.000
W32 Handgun discharge	0.006	0.994	0.000
W31 Contact with other and unspecified machinery	0.006	0.994	0.000
W30 Contact with agricultural machinery	0.006	0.994	0.000
V04 Pedestrian injured in collision with heavy transport vehicle or bus	0.006	0.994	0.000
W27 Contact with nonpowered hand tool	0.006	0.994	0.000
D68.8 Other specified coagulation defects	0.006	0.994	0.000
W24 Contact with lifting and transmission devices, not elsewhere classified	0.006	0.994	0.000
W94 Exposure to high and low air pressure and changes in air pressure	0.006	0.994	0.000
D73.4 Cyst of spleen	0.006	0.994	0.000
W25.9 Unspecified place	0.006	0.994	0.000
W44.8 Other specified place	0.006	0.994	0.000
W28 Contact with powered lawn mower	0.006	0.994	0.000
Y35-Y36 Legal intervention and operations of war	0.006	0.994	0.000
Y10-Y34 Event of undetermined intent	0.006	0.994	0.000
X85-X99 Assault	0.006	0.994	0.000
X30-X39 Exposure to forces of nature	0.006	0.994	0.000
W65-W74 Accidental drowning and submersion	0.006	0.994	0.000
V60-V69 Occupant of heavy transport vehicle injured in transport accident	0.006	0.994	0.000
V30-V39 Occupant of three-wheeled motor vehicle injured in transport accident	0.006	0.994	0.000
X10-X19 Contact with heat and hot substances	0.006	0.994	0.000
Y42.9 Other and unspecified hormone antagonists	0.006	0.994	0.000
Y42.4 Oral contraceptives	0.006	0.994	0.000
Y42.2 Antithyroid drugs	0.006	0.994	0.000
Y42.1 Thyroid hormones and substitutes	0.006	0.994	0.000
W55 Bitten or struck by other mammals	0.006	0.994	0.000
D84 Other immunodeficiencies	0.006	0.994	0.000
V93.4 Sailboat	0.006	0.994	0.000
V89 Motor- or nonmotor-vehicle accident, type of vehicle unspecified	0.006	0.994	0.000
V70-V79 Bus occupant injured in transport accident	0.006	0.994	0.000
D73.9 Disease of spleen, unspecified	0.006	0.994	0.000
D73.2 Chronic congestive splenomegaly	0.006	0.994	0.000
V48 Car occupant injured in noncollision transport accident	0.006	0.994	0.000
W50 Hit, struck, kicked, twisted, bitten or scratched by another person	0.006	0.994	0.000
K07.4 Malocclusion, unspecified	0.006	0.994	0.000
D73.8 Other diseases of spleen	0.006	0.994	0.000
K07.2 Anomalies of dental arch relationship	0.006	0.994	0.000
V47 Car occupant injured in collision with fixed or stationary object	0.006	0.994	0.000
V46 Car occupant injured in collision with other nonmotor vehicle	0.006	0.994	0.000
V45 Car occupant injured in collision with railway train or railway vehicle	0.006	0.994	0.000
V42 Car occupant injured in collision with two- or three-wheeled motor vehicle	0.006	0.994	0.000
V41 Car occupant injured in collision with pedal cycle	0.006	0.994	0.000
V40 Car occupant injured in collision with pedestrian or animal	0.006	0.994	0.000
W51 Striking against or bumped into by another person	0.006	0.994	0.000
D68.3 Haemorrhagic disorder due to circulating anticoagulants	0.006	0.994	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.005	0.994	0.001
W22.8 Other specified place	0.006	0.994	0.000
W22.6 Industrial and construction area	0.006	0.994	0.000
W22.4 Street and highway	0.006	0.994	0.000
W22.0 Home	0.006	0.994	0.000
W22.7 Farm	0.006	0.994	0.000
W22.1 Residential institution	0.006	0.994	0.000
K07.6 Temporomandibular joint disorders	0.006	0.994	0.000
W22.2 School, other institution and public administrative area	0.006	0.994	0.000
D84.9 Immunodeficiency, unspecified	0.006	0.994	0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.006	0.994	0.000
Y66 Nonadministration of surgical and medical care	0.006	0.994	0.000
W22.3 Sports and athletics area	0.006	0.994	0.000
W29.8 Other specified place	0.006	0.994	0.000
W29.6 Industrial and construction area	0.006	0.994	0.000
W29.0 Home	0.006	0.994	0.000
W29.7 Farm	0.006	0.994	0.000
W29.4 Street and highway	0.006	0.994	0.000
W29.3 Sports and athletics area	0.006	0.994	0.000
W29.2 School, other institution and public administrative area	0.006	0.994	0.000
W29.1 Residential institution	0.006	0.994	0.000
X20-X29 Contact with venomous animals and plants	0.006	0.994	0.000
Y00-Y09 Assault	0.006	0.994	0.000
Y42.7 Androgens and anabolic congeners	0.006	0.994	0.000
V94 Other and unspecified water transport accidents	0.005	0.994	0.000
V92 Water-transport-related drowning and submersion without accident to watercraft	0.005	0.994	0.000
V91 Accident to watercraft causing other injury	0.005	0.994	0.000
V90 Accident to watercraft causing drowning and submersion	0.005	0.994	0.000
X50-X57 Overexertion, travel and privation	0.005	0.994	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations